首页> 外国专利> Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer

Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer

机译:靶向o-乙酰化的gd2神经节苷脂作为癌症干细胞癌症的新治疗和诊断策略

摘要

An antibody recognizing the O-acetylated-GD2 ganglioside for the treatment of Cancer Stem Cells (CSC) cancer, a pharmaceutical composition including the antibody for treating a CSC cancer and a method for treating a CSC cancer in a patient in need thereof, the method including administering the antibody to the patient. A method for diagnosing a CSC, the use of the O-acetylated-GD2 ganglioside as a biomarker of CSC cancer, and a method for predicting the response of a subject affected with CSC cancer to a treatment with the antibody or the composition are also described.
机译:识别用于治疗癌症干细胞(CSC)癌症的O-乙酰化GD2神经节苷脂的抗体,包含用于治疗CSC癌症的抗体的药物组合物以及用于在有此需要的患者中治疗CSC癌症的方法,该方法包括向患者施用抗体。还描述了用于诊断CSC的方法,O-乙酰化的GD2神经节苷脂作为CSC癌症的生物标志物的用途以及预测受CSC癌症影响的受试者对用抗体或组合物治疗的反应的方法。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号